Lenstec SBL-3 Multifocal Intraocular Lens for Cataract Surgery Approved by FDA for US Sale – NBCNEWS

  • Whatsapp

Lenstec Inc. announced that its SBL-3 IOL has been approved by the FDA.

Read More

ST. PETERSBURG, fl., July 28, 2022 /PRNewswire/ — The Lenstec SBL-3 IOL (segmented bifocal lens) is a next-generation asymmetric multifocal refractive IOL that provides patients with near, intermediate and distance vision. The patented design improves contrast sensitivity and minimizes halo and glare (dysphotopsias) often associated with other traditional ‘concentric ring’ multifocal IOLs.

The segmented optical design is the first of its kind in the US. Lenstec’s patented four-point mount and design give surgeons confidence in the effective lens position of the IOL within the capsule. Availability in 0.25 diopter increments, along with the industry’s tightest tolerances (+/- 0.11 diopter of the labeled power), helps surgeons achieve the best possible refractive results.

James LodenMD (Nashville, Tennessee), a principal investigator in the FDA study, notes, “SBL-3 lens patients reported high-quality distance and near vision, without the headaches of severe dysphotopsia problems, and we had no complaints about computer vision.”

Sebastian HeersinkMD (Dothan, AL), another principal investigator of the FDA study, stated, “In my own experience with the SBL-3, I have been very impressed with the quality and range of functional vision patients obtained, as well as their overall happiness. It performs well in low light and patients report excellent driving at night. It’s a great lens that I would have implanted in my own eyes without hesitation.”

About Lenstec

Lenstec is a leading designer and manufacturer of intraocular lenses (IOLs) for the treatment of patients with a range of visual disorders. Founded in 1992, the company is committed to improving opportunities for ophthalmic professionals and their patients around the world.

More information about the SBL-3 and Lenstec’s line of Precision Series IOLs is available at: www.lenstec.com

The content is from PR NewsWire. DKODING Media is not responsible for the content offered or any links related to this content. DKODING Media is not responsible for the accuracy, timeliness or quality of the content.

Related posts

Leave a Reply